Summit Corporation Aktie
WKN DE: A115K3 / ISIN: GB00BN40HZ01
09.09.2025 11:51:00
|
Is Summit Therapeutics a Buy, Sell, or Hold Now?
A rocky road for Summit Therapeutics got a lot rougher over the weekend. The company presented somewhat disappointing data for the experimental cancer drug it's developing.When the market opened on Monday, Sep. 8, shares of the pre-commercial biotech stock had fallen 17% from the previous session's closing price. While ivonescimab's path forward isn't as clear as investors had hoped it would be, it's still a long way from hopeless.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!